New research highlights a multimodal machine-learning strategy for earlier Parkinson’s disease detection by combining quantitative susceptibility mapping (QSM) with magnetic resonance spectroscopy (MRS). The approach is aimed at extracting disease-relevant signal patterns from brain imaging modalities that capture different biochemical and structural properties. By integrating QSM and MRS features, the work seeks to improve diagnostic performance compared with single-modality analyses, a challenge that has persisted as clinicians try to move beyond symptom-based identification. The study frames multimodal fusion as the pathway to more precise early classification. For developers of clinical decision tools and AI imaging systems, the key signal is that neuroimaging feature engineering—paired with model development—continues to shift toward combining complementary MRI physics-based readouts. While the provided coverage does not list trial status or external validation details, the headline development is the move toward QSM–MRS fusion models for Parkinson’s early detection workflows.